[{"address1": "655 Elizabeth Street", "city": "Melbourne", "state": "VIC", "zip": "3000", "country": "Australia", "phone": "61 3 9389 1911", "fax": "61 3 9389 1434", "website": "https://www.csl.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "CSL Limited engages in the research, development, manufacture, market, and distribution of biopharmaceutical products and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment manufactures, markets, and distributes plasma products, gene therapies, and recombinants. This segment also offers therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. The CSL Seqirus segment manufactures, markets, and distributes influenza related products and pandemic services to governments. The CSL Vifor segment manufactures, markets, and distributes products in the therapeutic areas of iron deficiency and nephrology. It also licenses CSL intellectual property. CSL Limited was founded in 1916 and is headquartered in Melbourne, Australia.", "fullTimeEmployees": 29904, "companyOfficers": [{"maxAge": 1, "name": "Dr. Paul F. McKenzie Ph.D.", "age": 58, "title": "MD, CEO & Executive Director", "yearBorn": 1966, "fiscalYear": 2025, "totalPay": 4745548, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Joy Carolyn Linton B.Com., BComm, GAICD, Grad Dip AFI", "age": 59, "title": "Chief Financial Officer", "yearBorn": 1965, "fiscalYear": 2025, "totalPay": 2469250, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Andy  Schmeltz", "age": 53, "title": "Executive Vice President of CSL Behring", "yearBorn": 1971, "fiscalYear": 2025, "totalPay": 1588530, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Mary  Oates Ph.D.", "age": 61, "title": "Chief Operating Officer", "yearBorn": 1963, "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Chris  Cooper", "title": "Head of Investor Relations", "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Gregory  Boss B.S., BS(Hons), J.D.", "age": 63, "title": "Executive VP of Legal & General Counsel", "yearBorn": 1961, "fiscalYear": 2025, "totalPay": 1095171, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Roanne  Parry", "age": 51, "title": "Chief Human Resources Officer", "yearBorn": 1973, "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. William  Mezzanotte M.D., M.P.H.", "age": 65, "title": "Chief Medical Officer, Executive VP and Head of Research & Development", "yearBorn": 1959, "fiscalYear": 2025, "totalPay": 1455733, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mark  Hill B.A., M.B.A.", "age": 62, "title": "Chief Digital Information Officer & Executive VP", "yearBorn": 1962, "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Deirdre  BeVard", "title": "Senior Vice President of Research & Development Strategic Operations", "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1767139200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 68.75, "open": 68.41, "dayLow": 68.17, "dayHigh": 68.7, "regularMarketPreviousClose": 68.75, "regularMarketOpen": 68.41, "regularMarketDayLow": 68.17, "regularMarketDayHigh": 68.7, "dividendRate": 1.46, "dividendYield": 2.14, "exDividendDate": 1757462400, "payoutRatio": 0.4457, "fiveYearAvgDividendYield": 1.23, "beta": 0.256, "trailingPE": 22.191559, "volume": 36602, "regularMarketVolume": 36602, "averageVolume": 85311, "averageVolume10days": 190340, "averageDailyVolume10Day": 190340, "bid": 68.42, "ask": 68.68, "bidSize": 100, "askSize": 291, "marketCap": 66299633664, "fiftyTwoWeekLow": 65.13, "fiftyTwoWeekHigh": 105.66, "priceToSalesTrailing12Months": 4.26145, "fiftyDayAverage": 80.3376, "twoHundredDayAverage": 81.92375, "trailingAnnualDividendRate": 2.92, "trailingAnnualDividendYield": 0.042472728, "currency": "USD", "tradeable": false, "enterpriseValue": 44508897280, "forwardPE": 16.793652, "profitMargins": 0.19296, "floatShares": 483950648, "sharesOutstanding": 970001984, "heldPercentInsiders": 0.0, "heldPercentInstitutions": 0.00014999999, "impliedSharesOutstanding": 977510976, "bookValue": 39.931, "priceToBook": 1.7117027, "lastFiscalYearEnd": 1751241600, "nextFiscalYearEnd": 1782777600, "mostRecentQuarter": 1751241600, "earningsQuarterlyGrowth": 0.343, "netIncomeToCommon": 3001999872, "trailingEps": 3.08, "enterpriseToRevenue": 2.861, "enterpriseToEbitda": 9.067, "52WeekChange": -0.32433766, "SandP52WeekChange": 0.18469036, "lastDividendValue": 0.65, "lastDividendDate": 1741651200, "quoteType": "EQUITY", "currentPrice": 68.35, "targetHighPrice": 100.0, "targetLowPrice": 100.0, "targetMeanPrice": 100.0, "targetMedianPrice": 100.0, "recommendationKey": "none", "numberOfAnalystOpinions": 1, "totalCash": 2156999936, "totalCashPerShare": 4.455, "ebitda": 4909000192, "totalDebt": 11498000384, "quickRatio": 1.064, "currentRatio": 2.461, "totalRevenue": 15557999616, "debtToEquity": 53.711, "revenuePerShare": 16.071, "returnOnAssets": 0.06626, "returnOnEquity": 0.1537, "grossProfits": 8079000064, "freeCashflow": 1878499968, "operatingCashflow": 3560999936, "earningsGrowth": 0.333, "revenueGrowth": 0.049, "grossMargins": 0.51928, "ebitdaMargins": 0.31553, "operatingMargins": 0.18827, "financialCurrency": "USD", "symbol": "CSLLY", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "regularMarketChangePercent": -0.5818204, "regularMarketPrice": 68.35, "marketState": "CLOSED", "shortName": "CSL Ltd.", "fiftyDayAverageChange": -11.987602, "fiftyDayAverageChangePercent": -0.14921534, "twoHundredDayAverageChange": -13.573753, "twoHundredDayAverageChangePercent": -0.16568765, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "hasPrePostMarketData": false, "firstTradeDateMilliseconds": 1262097000000, "fullExchangeName": "OTC Markets OTCQX", "averageDailyVolume3Month": 85311, "fiftyTwoWeekLowChange": 3.2200012, "fiftyTwoWeekLowChangePercent": 0.0494396, "fiftyTwoWeekRange": "65.13 - 105.66", "fiftyTwoWeekHighChange": -37.310005, "fiftyTwoWeekHighChangePercent": -0.3531138, "fiftyTwoWeekChangePercent": -32.433765, "dividendDate": 1728432000, "earningsTimestamp": 1755547200, "earningsTimestampStart": 1755547200, "earningsTimestampEnd": 1755547200, "earningsCallTimestampStart": 1755561600, "earningsCallTimestampEnd": 1755561600, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": 3.08, "epsCurrentYear": 3.52349, "priceEpsCurrentYear": 19.39838, "corporateActions": [{"header": "Dividend", "message": "CSLLY announced a cash dividend of 0.81 with an ex-date of Sep. 10, 2025", "meta": {"eventType": "DIVIDEND", "dateEpochMs": 1757476800000, "amount": "0.81"}}], "regularMarketTime": 1757030400, "exchange": "OQX", "messageBoardId": "finmb_881503", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChange": -0.40000153, "regularMarketDayRange": "68.17 - 68.7", "longName": "CSL Limited", "trailingPegRatio": null, "__fetch_time": "2025-09-06"}]